Ocugen (OCGN) Net Equity Issued and Repurchased (2015 - 2026)

Ocugen (OCGN) has 10 years of Net Equity Issued and Repurchased data on file, last reported at $22.5 million in Q1 2026.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $22.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.0 million (up 2835.33% YoY) and the FY2025 annual result came in at $19.9 million, down 48.51% from the prior year.
• Net Equity Issued and Repurchased improved to $22.5 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $50.2 million in Q1 2022 to a low of -$145000.0 in Q1 2024.
• A 5-year average of $8.8 million and a median of $1.3 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 6031.25% in 2024, down 102.53% in 2024.
• Tracing OCGN's Net Equity Issued and Repurchased over 5 years: stood at $8.4 million in 2022, then slumped by 99.81% to $16000.0 in 2023, then soared by 6031.25% to $981000.0 in 2024, then soared by 55.76% to $1.5 million in 2025, then surged by 1372.51% to $22.5 million in 2026.
• The last three Net Equity Issued and Repurchased figures came in at $22.5 million (Q1 2026), $1.5 million (Q4 2025), and $981000.0 (Q4 2024), per Business Quant data.